67 results
S-1
EX-10.2
PRAX
Praxis Precision Medicines Inc
25 Sep 20
IPO registration
5:19pm
or expense is incurred for which indemnification, reimbursement or advancement of expenses can be provided under this Agreement; provided, however … , with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.
Section 6. Reimbursement for Expenses
S-1
EX-10.12
PRAX
Praxis Precision Medicines Inc
25 Sep 20
IPO registration
5:19pm
from the Start Date. The Company will provide Executive with a maximum relocation expense of $200,000, subject to the Expense Reimbursement Agreement … in furtherance or in connection with the performance of Executive’s duties hereunder, in accordance with the Company’s expense reimbursement policy
10-Q
EX-10.11
ubo8rmx
23 Nov 20
Quarterly report
4:16pm
10-Q
hlwqorgt
23 Nov 20
Quarterly report
4:16pm
S-1
EX-10.1
msxo10e3z
25 Sep 20
IPO registration
5:19pm
S-1/A
EX-10.1
625i2m103w
9 Oct 20
IPO registration (amended)
6:09am
DRS/A
3n62f3
28 Aug 20
Draft registration statement (amended)
12:00am
10-K
xekq5l
17 Mar 21
Annual report
8:33am
DRS
msq8 7ecqxv3rmzbt
22 Jul 20
Draft registration statement
12:00am
S-1
eo33d5p8aie4 rfq
25 Sep 20
IPO registration
5:19pm
S-1/A
8d07sqan0n2wl33p6
9 Oct 20
IPO registration (amended)
6:09am
424B4
bs81ja epm54a
16 Oct 20
Prospectus supplement with pricing info
4:02pm